tiprankstipranks
Trending News
More News >

Shandong Xinhua Pharmaceutical Schedules Board Meeting for Annual Results

Story Highlights
Shandong Xinhua Pharmaceutical Schedules Board Meeting for Annual Results

Confident Investing Starts Here:

An announcement from Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) is now available.

Shandong Xinhua Pharmaceutical Company Limited has announced that its board of directors will hold a meeting on March 28, 2025, to consider and approve the audited annual results for the year ending December 31, 2024. The meeting will also discuss the recommendation of a final dividend and address any other business matters. This announcement indicates the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its market positioning and stakeholder relations.

More about Shandong Xinhua Pharmaceutical Company Limited Class H

Shandong Xinhua Pharmaceutical Company Limited is a joint stock company based in the People’s Republic of China, specializing in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products.

YTD Price Performance: -0.86%

Average Trading Volume: 3,321,745

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: HK$9.03B

See more data about 0719 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1